Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jun 30 | MLYS | Mineralys Therapeutics,… | SSELL◷ | 17,000 | $26.82 | $455.9K | -2.7% | Open the original filing on SEC.gov |
| Jun 30 | MLYS | Mineralys Therapeutics,… | SSELL◷ | 58,000 | $25.94 | $1.5M | -8.4% | Open the original filing on SEC.gov |
| Jun 29 | IMUX | Immunic, INC. | AGRANT◆ | 50,740 | — | — | — | Open the original filing on SEC.gov |
| Apr 29 | AVLN | Avalyn Pharma Inc. | AGRANT◆ | 26,978 | — | — | — | Open the original filing on SEC.gov |
| Apr 13 | MLYS | Mineralys Therapeutics,… | SSELL◷ | 15,730 | $26.83 | $422K | -2.2% | Open the original filing on SEC.gov |
| Mar 31 | MLYS | Mineralys Therapeutics,… | SSELL◷ | 453 | $27.05 | $12.3K | <0.1% | Open the original filing on SEC.gov |
| Mar 31 | MLYS | Mineralys Therapeutics,… | SSELL◷ | 55,183 | $26.54 | $1.5M | -7.2% | Open the original filing on SEC.gov |
| Mar 31 | MLYS | Mineralys Therapeutics,… | SSELL◷ | 19,364 | $25.50 | $493.8K | -2.5% | Open the original filing on SEC.gov |